PR PolyResearch

Join Free

NASDAQ

4D Molecular Therapeutics, Inc. (FDMT)

♥ 604 Thanks from members

4D Molecular Therapeutics, Inc. (FDMT) exhibits strong bullish momentum and high analyst support driven by AAV pipeline progress, despite increasing net losses and pre-commercial status reported in Q2 2026 financial updates.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Other Nasdaq Tickers

GraniteShares 2x Long AAPL Daily ETF (AAPB)

Apple Inc. (AAPL)

Direxion Daily AAPL Bear 1X ETF (AAPD)

Ascentage Pharma Group International - American Depository Shares (AAPG)

Direxion Daily AAPL Bull 2X ETF (AAPU)

Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)